Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$556M |
| 2 |
Eaton
ETN
|
+$521M |
| 3 |
Verisk Analytics
VRSK
|
+$352M |
| 4 |
Zimmer Biomet
ZBH
|
+$343M |
| 5 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$340M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$677M |
| 2 |
Lockheed Martin
LMT
|
+$569M |
| 3 |
Booz Allen Hamilton
BAH
|
+$491M |
| 4 |
Microsoft
MSFT
|
+$489M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$419M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.21% |
| 2 | Financials | 11.94% |
| 3 | Healthcare | 8.99% |
| 4 | Industrials | 8.12% |
| 5 | Consumer Discretionary | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLNA
3901
Filana Therapeutics
FLNA
$48.8M
| $23.1K | ﹤0.01% |
15,374
-599
| -4% | -$1.51K |
|
3902
Getty Images
GETY
$153M
| $22.6K | ﹤0.01% |
13,075
-85
| -0.6% | -$202 |
|
3903
Cardlytics
CDLX
$21.8M
| $22.4K | ﹤0.01% |
1,233
-3
| -0.2% | -$86 |
|
3904
Lineage Cell Therapeutics
LCTX
$272M
| $21.2K | ﹤0.01% |
46,897
+4,019
| +9% | +$2.36K |
|
3905
Microvision
MVIS
$89.5M
| $21K | ﹤0.01% |
16,932
-96
| -0.6% | -$134 |
|
3906
TherapeuticsMD
TXMD
$23.5M
| $20.8K | ﹤0.01% |
22,470
| – | – |
|
3907
Zentalis Pharmaceuticals
ZNTL
$340M
| $20.1K | ﹤0.01% |
12,617
-134,056
| -91% | -$289K |
|
3908
Humacyte
HUMA
$179M
| $19.7K | ﹤0.01% |
11,530
-25
| -0.2% | -$94 |
|
3909
PMV Pharmaceuticals
PMVP
$59.2M
| $19.6K | ﹤0.01% |
18,007
-4,800
| -21% | -$6.52K |
|
3910
Oxbridge Re Holdings
OXBR
$10.8M
| $18.9K | ﹤0.01% |
10,000
| – | – |
|
3911
Lightwave Logic
LWLG
$997M
| $17.1K | ﹤0.01% |
16,711
+61
| +0.4% | +$95 |
|
3912
CBAK Energy Technology Ltd
CBAT
$44.4M
| $15.9K | ﹤0.01% |
19,999
-1
| -0% | -$1 |
|
3913
SkinHealth Systems
SKIN
$88.3M
| $15.2K | ﹤0.01% |
11,374
-63
| -0.6% | -$96 |
|
3914
Nerdy
NRDY
$105M
| $14.6K | ﹤0.01% |
10,278
+183
| +2% | +$308 |
|
3915
Gold Royalty Corp
GROY
$602M
| $14.4K | ﹤0.01% |
10,000
-200
| -2% | -$272 |
|
3916
Snail Inc
SNAL
$42.4M
| $13.3K | ﹤0.01% |
+3,020
| New | +$29.7K |
|
3917
GrowGeneration
GRWG
$87.1M
| $13.2K | ﹤0.01% |
12,247
-135
| -1% | -$181 |
|
3918
Alector
ALEC
$171M
| $13.1K | ﹤0.01% |
10,686
+100
| +0.9% | +$163 |
|
3919
Polestar Automotive Holding UK
PSNY
$2.14B
| $12.8K | ﹤0.01% |
+406
| New | +$13.4K |
|
|
MAPS
3920
DELISTED
WM TECHNOLOGY INC A
MAPS
| $12.7K | ﹤0.01% |
11,231
-73
| -0.6% | -$97 |
|
3921
Wheels Up
UP
$210M
| $12K | ﹤0.01% |
593
+1
| +0.2% | +$28 |
|
3922
Neumora Therapeutics
NMRA
$285M
| $11.1K | ﹤0.01% |
11,107
-107,567
| -91% | -$184K |
|
3923
Leslie's
LESL
$9.92M
| $10.9K | ﹤0.01% |
744
-20,410
| -96% | -$626K |
|
3924
Retractable Technologies
RVP
$19.8M
| $10.8K | ﹤0.01% |
15,400
| – | – |
|
3925
ProKidney
PROK
$314M
| $9.98K | ﹤0.01% |
11,388
+69
| +0.6% | +$96 |
|
Similar funds
Ameriprise's Q1 2025 Portfolio in Review
As of Q1 2025, Ameriprise held 4,203 positions worth $370B, down 4.9% from $390B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ameriprise's Q1 2025 filing shows 139 new, 1,887 increased, 1,861 reduced and 193 closed positions. Its largest new stake was Sandisk: 1,344,148 shares worth $64M. The largest sale was Amazon, an estimated $677M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q1 2025 buy was Sandisk: 1,344,148 shares worth $64M.
- Ameriprise added most to iShares 0-3 Month Treasury Bond ETF in Q1 2025, an estimated $556M increase.
- Ameriprise's biggest Q1 2025 reduction was Amazon, cutting an estimated $677M.
- Ameriprise fully exited Smartsheet Inc. in Q1 2025, selling an estimated $24.3M.
- Ameriprise's ten largest holdings make up 19% of its $370B portfolio in Q1 2025.
- Ameriprise opened 139 new positions and closed 193 in Q1 2025.
- Ameriprise's portfolio value fell 4.9% quarter-over-quarter to $370B.
Based on Ameriprise's 13F filing for Q1 2025, filed 14 May 2025.